dermal inflammatory response modulators (Cellegy)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedermal inflammatory response modulators (Cellegy)
Drug Alias NameCellidermskin barrier repair technology (Cellegy)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationDermatitisSkin Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamis Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsInflammationDermatitisSkin Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A